N-[4-(quinolin-4-yloxy) cyclohexyl (methyl)](hetero) arylcarboxamides as androgen receptor antagonist, production and use thereof as medicinal products
The invention relates to N-[4-(quinolin-4-yloxy)cyclohexyl(methyl)](hetero)arylcarboxamides, intermediates and methods for their production, use thereof for treating and/or preventing diseases and use thereof for producing medicinal products and use thereof for treating and/or preventing diseases, especially of hyperproliferative diseases.
